Pulmonary Embolism in 2021 and Beyond

Dear Colleagues,

With 900,000 patients affected and 100,000 deaths per year in the United States, pulmonary embolism is the third cause of cardiovascular death. Thromboembolic venous disease is a very active field of research, as there is still much progress to be made in the understanding of this protean pathology and its management.

The objective of this special issue entitled "Pulmonary embolism in 2021 and beyond" is to collect a series of original research articles and high-quality review articles with the aim of increasing knowledge about this pathology and improving its management.

We hope that this forward-looking and modern issue will set the stage for the management ofpulmonary embolism as it will be carried out in the coming years. All fields of research will be covered: pulmonary reperfusion strategies (directed catheter thrombolysis and others...), pulmonary embolism response team, diagnostic approach, management of specific populations, predictive medicine, artificial intelligence, basic science…

We trust the expertise and creativity of the authors to make their valuable contribution to this ambitious special issue.

Dr. Marc Laine
Prof. Dr. Laurent Bonello
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.